Literature DB >> 10221495

Melatonin: an antioxidant protects against cyclosporine-induced nephrotoxicity.

K V Kumar1, M U Naidu, A A Shifow, A Prayag, K S Ratnakar.   

Abstract

BACKGROUND: Cyclosporine (CsA) causes a dose-related decrease in renal function in experimental animals. Different mediators for CsA nephrotoxicity have been suggested; oxygen free radicals are one of them. In experimental model of Wistar rats, the role of antioxidant melatonin (Mel), the main product of pineal secretion, was investigated in CsA nephrotoxicity.
METHODS: Male Wistar rats were divided into four groups: saline control, 50 mg/kg CsA, 500 microg/kg Mel, and CsA + Mel. At the end of 14th day of treatment, blood urea, creatinine, malondialdehyde, and creatinine and lithium clearance were estimated. Histopathological examination of kidney from all the groups was performed.
RESULTS: CsA caused marked elevation in blood urea, serum creatinine, and plasma malondialdehyde and a decrease in creatinine and lithium clearance. Mel significantly antagonized CsA-induced renal impairment. Microcalcification in corticomedullary junction seen with CsA was prevented by Mel.
CONCLUSION: These results indicate that Mel, through its antioxidant properties, provides protection against CsA-induced nephrotoxicity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10221495     DOI: 10.1097/00007890-199904150-00022

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  8 in total

1.  Cyclosporin: nephro-protective as well as nephrotoxic?

Authors:  P W Mathieson
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

Review 2.  Prevention of vancomycin induced nephrotoxicity: a review of preclinical data.

Authors:  Sepideh Elyasi; Hossein Khalili; Shima Hatamkhani; Simin Dashti-Khavidaki
Journal:  Eur J Clin Pharmacol       Date:  2012-09-21       Impact factor: 2.953

3.  Differential effects of vanadium, tungsten and molybdenum on inhibition of glucose formation in renal tubules and hepatocytes of control and diabetic rabbits: beneficial action of melatonin and N-acetylcysteine.

Authors:  A Kiersztan; K Winiarska; J Drozak; M Przedlacka; M Wegrzynowicz; T Fraczyk; J Bryla
Journal:  Mol Cell Biochem       Date:  2004-06       Impact factor: 3.396

4.  Development of biodegradable nanoparticles for oral delivery of ellagic acid and evaluation of their antioxidant efficacy against cyclosporine A-induced nephrotoxicity in rats.

Authors:  K Sonaje; J L Italia; G Sharma; V Bhardwaj; K Tikoo; M N V Ravi Kumar
Journal:  Pharm Res       Date:  2007-03-22       Impact factor: 4.580

5.  Melatonin attenuates vascular calcification by inhibiting mitochondria fission via an AMPK/Drp1 signalling pathway.

Authors:  Wei Ren Chen; Yu Jie Zhou; Yuan Sha; Xue Ping Wu; Jia Qi Yang; Fang Liu
Journal:  J Cell Mol Med       Date:  2020-05-05       Impact factor: 5.310

6.  Renoprotective Effects of Melatonin against Vancomycin-Related Acute Kidney Injury in Hospitalized Patients: a Retrospective Cohort Study.

Authors:  Thomas S Hong; Kelsey Briscese; Marshall Yuan; Kiran Deshpande; Lauren M Aleksunes; Luigi Brunetti
Journal:  Antimicrob Agents Chemother       Date:  2021-08-17       Impact factor: 5.191

7.  Melatonin Attenuates Calcium Deposition from Vascular Smooth Muscle Cells by Activating Mitochondrial Fusion and Mitophagy via an AMPK/OPA1 Signaling Pathway.

Authors:  Wei Ren Chen; Yu Jie Zhou; Jia Qi Yang; Fang Liu; Xue Ping Wu; Yuan Sha
Journal:  Oxid Med Cell Longev       Date:  2020-04-24       Impact factor: 6.543

8.  Melatonin Attenuates β-Glycerophosphate-Induced Calcification of Vascular Smooth Muscle Cells via a Wnt1/β-Catenin Signaling Pathway.

Authors:  Wei Ren Chen; Yu Jie Zhou; Jia Qi Yang; Fang Liu; Ying Xin Zhao; Yuan Sha
Journal:  Biomed Res Int       Date:  2019-12-11       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.